| Year |
Citation |
Score |
| 2024 |
Zakrzewski JL, Suh D, Markley JC, Smith OM, King C, Goldberg GL, Jenq R, Holland AM, Grubin J, Cabrera-Perez J, Brentjens RJ, Lu SX, Rizzuto G, Sant'Angelo DB, Riviere I, et al. Author Correction: Tumor immunotherapy across MHC barriers using allogeneic T-cell precursors. Nature Biotechnology. PMID 38531977 DOI: 10.1038/s41587-024-02205-3 |
0.735 |
|
| 2020 |
Landau HJ, Yellapantula V, Diamond BT, Rustad EH, Maclachlan KH, Gundem G, Medina-Martinez J, Ossa JA, Levine MF, Zhou Y, Kappagantula R, Baez P, Attiye M, Makohon-Moore A, Zhang L, ... ... Lu S, et al. Accelerated single cell seeding in relapsed multiple myeloma. Nature Communications. 11: 3617. PMID 32680998 DOI: 10.1038/S41467-020-17459-Z |
0.37 |
|
| 2020 |
Lu SX. Modern treatments and future directions for newly diagnosed multiple myeloma patients. Best Practice & Research. Clinical Haematology. 33: 101151. PMID 32139016 DOI: 10.1016/J.Beha.2020.101151 |
0.339 |
|
| 2019 |
Pastore A, Gaiti F, Lu SX, Brand RM, Kulm S, Chaligne R, Gu H, Huang KY, Stamenova EK, Béguelin W, Jiang Y, Schulman RC, Kim KT, Alonso A, Allan JN, et al. Corrupted coordination of epigenetic modifications leads to diverging chromatin states and transcriptional heterogeneity in CLL. Nature Communications. 10: 1874. PMID 31015400 DOI: 10.1038/S41467-019-09645-5 |
0.318 |
|
| 2019 |
Inoue D, Guo-Liang C, Liu B, Lee SC, Michel BC, Pangallo J, D'Avino AR, North K, Bitner LE, Xiao M, Kobayashi S, Yoshimi A, Cho H, Lu SX, Taylor J, et al. Spliceosomal Disruption of the Non-Canonical SWI/SNF Chromatin Remodeling Complex in SF3B1 Mutant Leukemias Blood. 134: 637-637. DOI: 10.1182/Blood-2019-124616 |
0.325 |
|
| 2018 |
Landgren O, Thoren K, Hultcrantz M, Lesokhin AM, Lendvai N, Mailankody S, Smith EL, Hassoun H, Lu SX, Mastey D, Salcedo M, Diab V, Sams A, Verducci D, Jones K, et al. Bone Marrow-Based and Longitudinal Blood-Based MRD Tracking in Newly Diagnosed Multiple Myeloma Patients Treated with Daratumumab, Carfilzomib, Lenalidomide and Dexamethasone (DKRd): A Correlative and Clinical Phase II Study Blood. 132: 3281-3281. DOI: 10.1182/Blood-2018-99-114311 |
0.311 |
|
| 2018 |
Lee SC, North K, Chen C, Kim E, Lu SX, Ki M, Garippa R, Lowe SW, Bradley RK, Abdel-Wahab OI. Dependency of Spliceosomal Mutant MDS on Innate Immune Signaling Blood. 132: 937-937. DOI: 10.1182/Blood-2018-99-111552 |
0.38 |
|
| 2018 |
Lu SX, Wang E, Pastore A, Xufeng C, Imig J, Lee SC, Ghebrechristos Y, Yoshimi A, Bitner LE, Ki M, Kloetgen A, Lin K, Tibes R, Krainer AR, Uehara T, et al. Therapeutic Targeting of an RNA Splicing Factor Network for the Treatment of Myeloid Neoplasms Blood. 132: 427-427. DOI: 10.1182/Blood-2018-99-111430 |
0.374 |
|
| 2017 |
Yoshimi A, Balasis ME, Vedder A, Feldman K, Ma Y, Zhang H, Lee SC, Letson C, Niyongere S, Lu SX, Ball M, Taylor J, Zhang Q, Zhao Y, Youssef S, et al. Robust patient-derived xenografts of MDS/MPN overlap syndromes capture the unique characteristics of CMML and JMML. Blood. PMID 28576879 DOI: 10.1182/Blood-2017-01-763219 |
0.446 |
|
| 2016 |
Lu SX, Abdel-Wahab O. Genetic drivers of vulnerability and resistance in relapsed acute lymphoblastic leukemia. Proceedings of the National Academy of Sciences of the United States of America. PMID 27663730 DOI: 10.1073/Pnas.1613836113 |
0.332 |
|
| 2011 |
Lu SX, Kappel LW, Charbonneau-Allard AM, Atallah R, Holland AM, Turbide C, Hubbard VM, Rotolo JA, Smith M, Suh D, King C, Rao UK, Yim N, Bautista JL, Jenq RR, et al. Ceacam1 separates graft-versus-host-disease from graft-versus-tumor activity after experimental allogeneic bone marrow transplantation. Plos One. 6: e21611. PMID 21760897 DOI: 10.1371/Journal.Pone.0021611 |
0.783 |
|
| 2010 |
Lu SX, Holland AM, Na IK, Terwey TH, Alpdogan O, Bautista JL, Smith OM, Suh D, King C, Kochman A, Hubbard VM, Rao UK, Yim N, Liu C, Laga AC, et al. Absence of P-selectin in recipients of allogeneic bone marrow transplantation ameliorates experimental graft-versus-host disease. Journal of Immunology (Baltimore, Md. : 1950). 185: 1912-9. PMID 20622117 DOI: 10.4049/Jimmunol.0903148 |
0.78 |
|
| 2010 |
Penack O, Henke E, Suh D, King CG, Smith OM, Na IK, Holland AM, Ghosh A, Lu SX, Jenq RR, Liu C, Murphy GF, Lu TT, May C, Scheinberg DA, et al. Inhibition of neovascularization to simultaneously ameliorate graft-vs-host disease and decrease tumor growth. Journal of the National Cancer Institute. 102: 894-908. PMID 20463307 DOI: 10.1093/Jnci/Djq172 |
0.741 |
|
| 2010 |
Na IK, Lu SX, Yim NL, Goldberg GL, Tsai J, Rao U, Smith OM, King CG, Suh D, Hirschhorn-Cymerman D, Palomba L, Penack O, Holland AM, Jenq RR, Ghosh A, et al. The cytolytic molecules Fas ligand and TRAIL are required for murine thymic graft-versus-host disease. The Journal of Clinical Investigation. 120: 343-56. PMID 19955659 DOI: 10.1172/Jci39395 |
0.798 |
|
| 2010 |
van den Brink MR, Porter DL, Giralt S, Lu SX, Jenq RR, Hanash A, Bishop MR. Relapse after allogeneic hematopoietic cell therapy. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 16: S138-45. PMID 19857588 DOI: 10.1016/J.Bbmt.2009.10.023 |
0.477 |
|
| 2010 |
Lu SX, Palomba ML, Na I-, Terwey TH, Alpdogan O, Bautista JL, Smith M, Suh D, King CG, Rao UK, Yim N, Jenq RR, Zakrzewski JL, Holland AM, Penack O, et al. P-Selectin Regulates Leukocyte Trafficking And Experimental Graft-Versus-Host-Disease After Allogeneic Bone Marrow Transplantation Biology of Blood and Marrow Transplantation. 16. DOI: 10.1016/J.Bbmt.2009.12.453 |
0.728 |
|
| 2010 |
Lu SX, Na I-, Yim N, Goldberg GL, Tsai J, Rao UK, Smith M, King CG, Suh D, Hirschorn-Cymerman D, Palomba ML, Penack O, Holland AM, Jenq RR, Ghosh A, et al. TRAIL/DR5 Interactions Are Important For Mediating Thymic Damage After Allogeneic Bone Marrow Transplantation Biology of Blood and Marrow Transplantation. 16. DOI: 10.1016/J.Bbmt.2009.12.452 |
0.701 |
|
| 2010 |
Ghosh A, Holland AM, Kappel LW, Dogan Y, Yim N, Rao U, Smith OM, Jenq RR, Zakrzewski J, Na I-, Lu S, Tsai J, Penack O, Hanash A, Sauer MG, et al. Over-Expression Of Trail On Donor T Cells Simultaneously Ameliorates GVHD And Enhances GVT Biology of Blood and Marrow Transplantation. 16. DOI: 10.1016/J.Bbmt.2009.12.434 |
0.784 |
|
| 2009 |
Penack O, Smith OM, Cunningham-Bussel A, Liu X, Rao U, Yim N, Na IK, Holland AM, Ghosh A, Lu SX, Jenq RR, Liu C, Murphy GF, Brandl K, van den Brink MR. NOD2 regulates hematopoietic cell function during graft-versus-host disease. The Journal of Experimental Medicine. 206: 2101-10. PMID 19737867 DOI: 10.1084/jem.20090623 |
0.783 |
|
| 2009 |
Rotolo JA, Stancevic B, Lu SX, Zhang J, Suh D, King CG, Kappel LW, Murphy GF, Liu C, Fuks Z, van den Brink MR, Kolesnick R. Cytolytic T cells induce ceramide-rich platforms in target cell membranes to initiate graft-versus-host disease. Blood. 114: 3693-706. PMID 19666872 DOI: 10.1182/Blood-2008-11-191148 |
0.82 |
|
| 2009 |
Jenq RR, King CG, Volk C, Suh D, Smith OM, Rao UK, Yim NL, Holland AM, Lu SX, Zakrzewski JL, Goldberg GL, Diab A, Alpdogan O, Penack O, Na IK, et al. Keratinocyte growth factor enhances DNA plasmid tumor vaccine responses after murine allogeneic bone marrow transplantation. Blood. 113: 1574-80. PMID 19011222 DOI: 10.1182/Blood-2008-05-155697 |
0.779 |
|
| 2009 |
Penack O, Smith OM, Yim N, Rao U, Ghosh A, Murphy GF, Holland AM, Jenq RR, Lu SX, Na I, van den Brink MR. NOD2 Regulates Hematopoietic Cell Function During Graft-Versus-Host Disease. Blood. 114: 2453-2453. DOI: 10.1182/BLOOD.V114.22.2453.2453 |
0.448 |
|
| 2009 |
Na I, Lu SX, Yim NL, Goldberg GL, Tsai J, Rao UK, Smith OM, King C, Suh D, Hirschhorn-Cymerman D, Palomba ML, Penack O, Holland AM, Jenq RR, Ghosh A, et al. TRAIL/ DR5 Interactions Are Important for Thymic Damage After Allogeneic Bone Marrow Transplantation. Blood. 114: 234-234. DOI: 10.1182/Blood.V114.22.234.234 |
0.795 |
|
| 2009 |
Lu SX, Palomba ML, Na I, Terwey T, Alpdogan O, Bautista JL, Smith MO, Suh D, King C, Rao U, Yim N, Jenq RR, Zakrzewski JL, Holland AM, Penack O, et al. P-Selectin in Recipients of Allogeneic Bone Marrow Transplantation Regulates Experimental Graft-Versus-Host-Disease. Blood. 114: 1335-1335. DOI: 10.1182/Blood.V114.22.1335.1335 |
0.779 |
|
| 2009 |
Lu SX, Na I-, Goldberg GL, Ghosh A, Hirschhorn-Cymerman D, King CG, Smith OM, Suh D, Rao U, Yim N, Holland AM, Penack O, Jenq RR, Teisch L, Meykler S, et al. The T Cell Cytolytic Molecules Fas Ligand And Trail, The Trafficking Molecules CCR9, β7 Integrin And PSGL1, And The Immune Modulating Molecules OX40 And Ceacam1 Are Required For Thymic Graft-Versus-Host Disease Biology of Blood and Marrow Transplantation. 15: 123. DOI: 10.1016/J.Bbmt.2008.12.379 |
0.712 |
|
| 2009 |
Lu S, Willis L, Charbonneau-Allard A, Atallah R, Holland A, Turbide C, Hubbard V, Rotolo J, Smith O, Suh D, King C, Rao U, Yim N, Kochman A, Bautista J, et al. Ceacam1 Regulates Experimental Graft-Versus-Host-Disease Biology of Blood and Marrow Transplantation. 15: 13. DOI: 10.1016/J.Bbmt.2008.12.038 |
0.686 |
|
| 2009 |
Penack O, Henke E, Suh D, King C, Smith M, Na I, Holland A, Ghosh A, Lu S, Jenq R, Liu C, May C, Murphy G, Lu T, Gao D, et al. Depletion of Vascular Endothelial Progenitor Cells Simultaneously Ameliorates GVHD and Inhibits Tumor Growth Biology of Blood and Marrow Transplantation. 15: 1. DOI: 10.1016/J.Bbmt.2008.12.007 |
0.676 |
|
| 2008 |
Lu SX, Alpdogan O, Lin J, Balderas R, Campos-Gonzalez R, Wang X, Gao GJ, Suh D, King C, Chow M, Smith OM, Hubbard VM, Bautista JL, Cabrera-Perez J, Zakrzewski JL, et al. STAT-3 and ERK 1/2 phosphorylation are critical for T-cell alloactivation and graft-versus-host disease. Blood. 112: 5254-8. PMID 18838616 DOI: 10.1182/Blood-2008-03-147322 |
0.591 |
|
| 2008 |
Alpdogan SO, Lu SX, Patel N, McGoldrick S, Suh D, Budak-Alpdogan T, Smith OM, Grubin J, King C, Goldberg GL, Hubbard VM, Kochman AA, van den Brink MR. Rapidly proliferating CD44hi peripheral T cells undergo apoptosis and delay posttransplantation T-cell reconstitution after allogeneic bone marrow transplantation. Blood. 112: 4755-64. PMID 18815289 DOI: 10.1182/Blood-2008-02-142737 |
0.606 |
|
| 2008 |
Zakrzewski JL, Suh D, Markley JC, Smith OM, King C, Goldberg GL, Jenq R, Holland AM, Grubin J, Cabrera-Perez J, Brentjens RJ, Lu SX, Rizzuto G, Sant'Angelo DB, Riviere I, et al. Tumor immunotherapy across MHC barriers using allogeneic T-cell precursors. Nature Biotechnology. 26: 453-61. PMID 18376399 DOI: 10.1038/Nbt1395 |
0.784 |
|
| 2008 |
Penack O, Henke E, Suh D, King C, Smith MO, Na I, Holland A, Ghosh A, Lu SX, Jenq R, Liu C, Murphy GF, Lu T, May C, Scheinberg DA, et al. Depletion of Vascular Endothelial Progenitor Cells Inhibits Inflammation Blood. 112: 694-694. DOI: 10.1182/Blood.V112.11.694.694 |
0.781 |
|
| 2008 |
Na I, Lu SX, Goldberg GL, Hirschhorn-Cymerman DD, King CG, Smith OM, Suh D, Rao U, Yim N, Holland AM, Penack O, Jenq RR, Ghosh A, Teisch L, Meykler S, et al. The T Cell Cytolytic Molecules Fas Ligand and TRAIL, the Trafficking Molecules CCR9, β7 Integrin and PSGL-1, and the Immune Modulating Molecules OX40, CEACAM1, and CTLA4 Are Required for Thymic Graft-Versus-Host Disease Blood. 112: 65-65. DOI: 10.1182/Blood.V112.11.65.65 |
0.8 |
|
| 2008 |
Zakrzewski JL, Suh D, Markley JC, Smith OM, King C, Goldberg G, Jenq R, Holland AM, Grubin J, Cabrera-Perez J, Lu SX, Rizzuto G, Sant'Angelo DB, Riviere I, Sadelain M, et al. 344: Off-the-Shelf Tumor Immunotherapy with Genetically Enhanced Allogeneic T-Cell Precursors Biology of Blood and Marrow Transplantation. 14: 126. DOI: 10.1016/J.Bbmt.2007.12.354 |
0.741 |
|
| 2007 |
Ramirez-Montagut T, Chow A, Kochman AA, Smith OM, Suh D, Sindhi H, Lu S, Borsotti C, Grubin J, Patel N, Terwey TH, Kim TD, Heller G, Murphy GF, Liu C, et al. IFN-gamma and Fas ligand are required for graft-versus-tumor activity against renal cell carcinoma in the absence of lethal graft-versus-host disease. Journal of Immunology (Baltimore, Md. : 1950). 179: 1669-80. PMID 17641033 DOI: 10.4049/Jimmunol.179.3.1669 |
0.589 |
|
| 2007 |
Borsotti C, Franklin AR, Lu SX, Kim TD, Smith OM, Suh D, King CG, Chow A, Liu C, Alpdogan O, van den Brink MR. Absence of donor T-cell-derived soluble TNF decreases graft-versus-host disease without impairing graft-versus-tumor activity. Blood. 110: 783-6. PMID 17395784 DOI: 10.1182/Blood-2006-10-054510 |
0.665 |
|
| 2007 |
Lu SX, Willis L, Smith M, Suh D, King C, Bautista J, Chow M, Cabrera-Perez J, Hubbard V, Rotolo J, Liu C, Murphy G, Alpdogan O, Blumberg R, Holmes K, et al. CEACAM-1 Is Involved in Graft-Versus-Host-Disease in Murine Allogeneic Bone Marrow Transplantation Models. Blood. 110: 67-67. DOI: 10.1182/Blood.V110.11.67.67 |
0.601 |
|
| 2007 |
Zakrzewski JL, Suh D, Smith OM, King C, Goldberg GL, Jenq R, Holland AM, Grubin J, Lu SX, Cabrera-Perez J, Rizzuto G, Sant’Angelo DB, van den Brink MR, Markley JC, Riviere I, et al. Targeted ‘Off-the-Shelf’ Tumor Immunotherapy Using Allogeneic T-Cell Precursors. Blood. 110: 579-579. DOI: 10.1182/Blood.V110.11.579.579 |
0.791 |
|
| 2007 |
Lu SX, Alpdogan O, Campos R, Wang X, Gao G, Chow M, Lin J, Suh D, King C, Hubbard VM, Bautista JL, Kochman AA, Zakrzewski JL, Smith OM, Grubin J, et al. Discovery and Validation of STAT-3 and ERK1/2 Phosphorylation as Critical for the Function of Alloactivated T Cells in Acute Graft-Versus-Host-Disease Via a Novel Technique for Drug Discovery. Blood. 110: 3236-3236. DOI: 10.1182/Blood.V110.11.3236.3236 |
0.571 |
|
| 2007 |
Brink MRMvd, Willis L, Bautista J, Chow M, Smith OM, Cabrera-Perez J, Suh D, King C, Zakrzewski J, Kochman A, Hubbard V, Turbide C, Beauchemin N, Lu SX. 330: Carcinoembryonic antigen related cell adhesion molecule 1 is an important suppressor of intestinal and systemic acute graft-versus-host-disease Biology of Blood and Marrow Transplantation. 13: 120. DOI: 10.1016/J.Bbmt.2006.12.335 |
0.446 |
|
| 2006 |
Zakrzewski JL, Kochman AA, Lu SX, Terwey TH, Kim TD, Hubbard VM, Muriglan SJ, Suh D, Smith OM, Grubin J, Patel N, Chow A, Cabrera-Perez J, Radhakrishnan R, Diab A, et al. Adoptive transfer of T-cell precursors enhances T-cell reconstitution after allogeneic hematopoietic stem cell transplantation. Nature Medicine. 12: 1039-47. PMID 16936725 DOI: 10.1038/Nm1463 |
0.656 |
|
| 2006 |
Ramirez-Montagut T, Chow A, Hirschhorn-Cymerman D, Terwey TH, Kochman AA, Lu S, Miles RC, Sakaguchi S, Houghton AN, van den Brink MR. Glucocorticoid-induced TNF receptor family related gene activation overcomes tolerance/ignorance to melanoma differentiation antigens and enhances antitumor immunity. Journal of Immunology (Baltimore, Md. : 1950). 176: 6434-42. PMID 16709800 DOI: 10.4049/Jimmunol.176.11.6434 |
0.512 |
|
| 2006 |
Alpdogan O, Hubbard VM, Smith OM, Patel N, Lu S, Goldberg GL, Gray DH, Feinman J, Kochman AA, Eng JM, Suh D, Muriglan SJ, Boyd RL, van den Brink MR. Keratinocyte growth factor (KGF) is required for postnatal thymic regeneration. Blood. 107: 2453-60. PMID 16304055 DOI: 10.1182/Blood-2005-07-2831 |
0.56 |
|
| 2006 |
Waldman E, Lu SX, Hubbard VM, Kochman AA, Eng JM, Terwey TH, Muriglan SJ, Kim TD, Heller G, Murphy GF, Liu C, Alpdogan O, van den Brink MR. Absence of beta7 integrin results in less graft-versus-host disease because of decreased homing of alloreactive T cells to intestine. Blood. 107: 1703-11. PMID 16291587 DOI: 10.1182/Blood-2005-08-3445 |
0.603 |
|
| 2006 |
Alpdogan O, Patel N, Suh D, Grubin J, McGoldrick S, Smith OM, Lu S, King C, Kochman A, Hubbard V, Brink MRMvd. Peripheral T Cell Apoptosis Is Associated with Homeostatic T Cell Proliferation and Plays a Significant Role in Post-Transplant Immune Deficiency. Blood. 108: 71-71. DOI: 10.1182/Blood.V108.11.71.71 |
0.602 |
|
| 2006 |
Zakrzewski JL, Kochman AA, Lu SX, Terwey T, Kim TD, Hubbard VM, Muriglan SJ, Suh D, Cabrera-Perez J, Heller G, Zuniga-Pflucker J-, Alpdogan O, Brink MRMvd. Adoptive transfer of in vitro generated T cell precursors improves T cell reconstitution and mediates graft-versus-tumor activity without graft-versus-host disease in allogeneic hematopoietic stem cell transplantation recipients Biology of Blood and Marrow Transplantation. 12: 82. DOI: 10.1016/J.Bbmt.2005.11.255 |
0.65 |
|
| 2006 |
Alpdogan O, McGoldrick S, Lu S, Patel N, Suh D, Smith OM, Brink MRMvd. Peripheral T cell apoptosis affects immune reconstitution after allogeneic BMT Biology of Blood and Marrow Transplantation. 12: 81. DOI: 10.1016/J.Bbmt.2005.11.252 |
0.525 |
|
| 2006 |
Lu SX, Chow MY, Hubbard VM, Suh DY, Kim TD, Kochman A, Zakrzewski J, Cabrera-Perez J, Alpdogan O, Brink MRMvd. T-cell signaling in allogeneic bone marrow transplantation Biology of Blood and Marrow Transplantation. 12: 24. DOI: 10.1016/J.Bbmt.2005.11.075 |
0.556 |
|
| 2005 |
Terwey TH, Kim TD, Kochman AA, Hubbard VM, Lu S, Zakrzewski JL, Ramirez-Montagut T, Eng JM, Muriglan SJ, Heller G, Murphy GF, Liu C, Budak-Alpdogan T, Alpdogan O, van den Brink MR. CCR2 is required for CD8-induced graft-versus-host disease. Blood. 106: 3322-30. PMID 16037386 DOI: 10.1182/Blood-2005-05-1860 |
0.601 |
|
| 2005 |
Lu SX, Hubbard VM, Chow MY, Kim TD, Suh DY, Kochman A, Zakrzewski J, Cabrera-Perez J, Alpdogan O, Brink MMRMvd. Signaling Profiles of T Cells during Allogeneic Hematopoietic Stem Cell Transplantation. Blood. 106: 1262-1262. DOI: 10.1182/Blood.V106.11.1262.1262 |
0.506 |
|
| 2005 |
Zakrzewski JL, Kochman A, Muriglan SJ, Lu S, Kim TD, Zuniga-Pflucker JC, Alpdogan O, Brink MRMvd. Adoptive transfer of in vitro-generated T cell precursors enhances posttransplant donor T cell reconstitution in recipients of an allogeneic hematopoietic stem cell transplantation Biology of Blood and Marrow Transplantation. 11: 4-5. DOI: 10.1016/J.Bbmt.2004.12.013 |
0.599 |
|
| Show low-probability matches. |